Moderna plans to offer Covid-19 vaccine with range of dosages after new deal with Swiss drugmaker Lonza

Moderna plans to offer Covid-19 vaccine with range of dosages after new deal with Swiss drugmaker Lonza

Were assuming that as of 2022, we are going to have a mix of dose levels on the market, a spokeswoman for Moderna told Reuters on Wednesday, following the announcement that Swiss firm Lonza could provide enough ingredients for 300 million doses of Modernas Covid-19 jab at a reduced dosage.

Modernas vaccine has been administered in a 100-microgram dose to date but following positive trial data, the company hopes to gain approval for a 50-microgram dose.

Lonzas Geleen site in the Netherlands will contribute to the supply of an additional 300 million doses of Modernas updated booster variant vaccine candidate per year at a 50-microgram dose.

Combined with a previous deal with ROVI in Granada, Spain, Moderna expects to supply the equivalent of 600 million 50-microgram doses each year from production sites within the EU.

Also on rt.com Moderna targets production of 3bn Covid vaccines in 2022, after CEO warns of future oversupply

The company has previously stated that a 50-microgram booster shot was sufficient to provide added immune response, even against the variants originating in Brazil and South Africa.

In April, Moderna President Stephen Hoge said the company sees huge demand for Covid-19 vaccines in 2022, which underpinned its decision to produce up to 3 billion doses next year.

A week previous, the companys CEO, Stephane Bancel, predicted that there would actually be too much supply globally in 2022, noting: Well, if anything that is a good problem to have in terms of dealing with the pandemic but its not a nice problem to have if youre the one manufacturing the vaccine I guess.

If you like this story, share it with a friend!


Published time: 2021-06-02 13:06:47
Source: www.rt.com